Rajaventhan Srirajaskanthan
Denmark Hill
Hill, ENG, United Kingdom
Hill, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review.
Journal: Journal of the Endocrine Society
Published: July 29, 2026
Management Strategies and Outcomes for Type 1 Gastric Neuroendocrine Tumors Measuring More Than 1 cm.
Journal: Clinical and translational gastroenterology
Published: March 19, 2026
Urine 5-HIAA and quality of life in neuroendocrine neoplasia. Is there an association?
Journal: Rare tumors
Published: January 18, 2026
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Journal: Lancet (London, England)
Published: December 04, 2025
Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series.
Journal: Endocrine oncology (Bristol, England)
Published: October 17, 2025
Epidemiology of Neuroendocrine Neoplasia Worldwide: A Review of the Literature (2012-2022).
Journal: Neuroendocrinology
Published: July 14, 2025
Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms.
Journal: Journal of neuroendocrinology
Published: May 29, 2025
The geographical distribution of neuroendocrine neoplasms in England (2012-2018).
Journal: Journal of neuroendocrinology
Published: January 16, 2025
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force.
Journal: Journal of neuroendocrinology
Published: October 05, 2024
Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 30, 2024
High Prevalence of Sarcopenia in Patients with Newly Diagnosed Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs), but No Association with the Risk of Surgical Complications.
Journal: Nutrients
Published: September 25, 2024
Last Updated: 09/26/2026